Shuzo Hamamoto

Dr. Shuzo Hamamoto

Department of Urology, Medical School, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Journal of Urology
Verified
Journal Article
Open access
KTKazumi Taguchi
Kazumi Taguchi
SHShuzo Hamamoto
Shuzo Hamamoto
AOAtsushi Okada
Atsushi Okada
TSTeruaki Sugino
Teruaki Sugino
RURei Unno
Rei Unno
Takahiro YasuiTakahiro Yasui
Takahiro Yasui
Purpose:We conducted a randomized, single-blind clinical trial comparing the surgical outcomes of robotic-assisted fluoroscopic-guided (RAF group) and ultrasound-guided (US group) renal acc...

6 June 2023 in International Journal of Urology
Verified
Journal Article
Closed access
YTyoshihiko tasaki
yoshihiko tasaki
SHShuzo Hamamoto
Shuzo Hamamoto
YSYosuke Sugiyama
Yosuke Sugiyama
NTNami Tomiyama
Nami Tomiyama
TNTaku Naiki
Taku Naiki
KKKazunori Kimura
Kazunori Kimura

2 February 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
TEToshiki Etani
Toshiki Etani
SKShuhei Kondo
Shuhei Kondo
TYTakahiro Yanase
Takahiro Yanase
TMToshiharu Morikawa
Toshiharu Morikawa
MAMaria Aoki
Maria Aoki
Takahiro YasuiTakahiro Yasui
Takahiro Yasui

29 March 2017 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
OGOn behalf of the SMART Study Group
On behalf of the SMART Study Group
SHShuzo Hamamoto
Shuzo Hamamoto
RURei Unno
Rei Unno
KTKazumi Taguchi
Kazumi Taguchi
TNTaku Naiki
Taku Naiki
Takahiro YasuiTakahiro Yasui
Takahiro Yasui

1 September 2016 in Urology
Verified
Journal Article
Closed access
TITakaaki Inoue
Takaaki Inoue
HKHidefumi Kinoshita
Hidefumi Kinoshita
SOShinsuke Okada
Shinsuke Okada
SHShuzo Hamamoto
Shuzo Hamamoto
MTMakoto Taguchi
Makoto Taguchi
TMTadashi Matsuda
Tadashi Matsuda

12 March 2018 in BMC Urology
Verified
Journal Article
Open access
PDF file
AOAtsushi Okada
Atsushi Okada
SHShuzo Hamamoto
Shuzo Hamamoto
KTKazumi Taguchi
Kazumi Taguchi
Rei UnnoRei Unno
Rei Unno
TSTeruaki Sugino
Teruaki Sugino
Takahiro YasuiTakahiro Yasui
Takahiro Yasui
We investigated the renoprotective ability of healthy people against kidney stone formation. To clarify intratubular crystal kinetics and processing in human kidneys, we performed a quantitative and morphological observation of nephrectomized renal parenchyma tissues. Clinical data and pathological samples from 60 patients who underwent radical nephrectomy for renal cancer were collected from June 2004 to June 2010. The patients were retrospectively classified as stone formers (SFs; n = 30, kidney stones detected by preoperative computed tomography) and non-stone formers (NSFs; n = 30, no kidney stone history). The morphology of parenchymal intratubular crystals and kidney stone-related gene and protein expression levels were examined in noncancerous renal sections from both groups. SFs had a higher smoking rate (P = 0.0097); lower red blood cell, hemoglobin, and hematocrit values; and higher urinary red blood cell, white blood cell, and bacterial counts than NSFs. Scanning electron microscopy revealed calcium-containing crystal deposits and crystal attachment to the renal tubular lumen in both groups. Both groups demonstrated crystal transmigration from the tubular lumen to the interstitium. The crystal diffusion analysis indicated a significantly higher crystal existing ratio in the medulla and papilla of SFs and a significantly higher number of papillary crystal deposits in SFs than NSFs. The expression analysis indicated relatively high osteopontin and CD68, low superoxide dismutase, and significantly lower Tamm–Horsfall protein expression levels in SFs. Multivariate logistic regression analysis involving the above factors found the presence of renal papillary crystals as a significant independent factor related to SFs (odds ratio 5.55, 95% confidence interval 1.08–37.18, P = 0.0395). Regardless of stone formation, intratubular crystals in the renal parenchyma seem to transmigrate to the interstitium. SFs may have reduced ability to eliminate renal parenchymal crystals, particularly those in the papilla region, than NSFs with associated gene expression profiles.